Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
about
Effects of Long-Term In Vivo Exposure to Di-2-Ethylhexylphthalate on Thyroid Hormones and the TSH/TSHR Signaling Pathways in Wistar RatsLong-term results of radiotherapy in anaplastic thyroid cancerPaclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.A case of dedifferentiated solitary fibrous tumor in the pelvis with TP53 mutation.Update: the status of clinical trials with kinase inhibitors in thyroid cancerBioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profileSPC24 is critical for anaplastic thyroid cancer progression.EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosisLenvatinib enhances the antitumor effects of paclitaxel in anaplastic thyroid cancerThe novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.A Case of a Rapidly Enlarging Neck Mass with Airway Compromise.Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.Anaplastic thyroid cancer: multimodal treatment results.A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcomeMolecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancersShort course high dose radiotherapy in the treatment of anaplastic thyroid carcinomaNovel approaches in anaplastic thyroid cancer therapymRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switchChemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight casesAnaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.miRNA expression in anaplastic thyroid carcinomas.ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude miceResults of combined treatment of anaplastic thyroid carcinoma (ATC)Evaluation of lentiviral-mediated expression of sodium iodide symporter in anaplastic thyroid cancer and the efficacy of in vivo imaging and therapyLate intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.Anaplastic Thyroid Cancer: Experience of the Philippine General HospitalCancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival RatesThyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.Analysis of patients with anaplastic thyroid cancer expected to have curative surgery.Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells.The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overviewPhase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss.Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling.Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.Anaplastic Thyroid Carcinoma, Version 2.2015.Anaplastic thyroid cancer: ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy.Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.
P2860
Q28817311-1AB68C50-F146-4810-BA92-13B9A862E31CQ30317480-64A340C1-CE6D-461C-AA21-0BB9C9CDB9FAQ33355378-638AF23B-05BB-40E2-A4DB-C6CBCB6CB0ECQ33416383-F5F0304A-B0DA-4125-89C8-BD9DD52DD6A7Q33570056-F93DEECA-D547-4EF1-9EE7-326937C71189Q33579281-0C9F8561-230D-45C7-B320-B88F5DE94627Q33591725-2648F549-495E-4431-9EE9-0574A53354ACQ33616879-556BE3F4-1E86-4628-AF56-3921399D588DQ33622678-193DCBB0-776B-4459-9CBC-02B4FDDC7C64Q33776640-8F939D01-B0EF-4EB6-969B-3F424AC34249Q33832214-EF76E281-D413-4E42-8FB4-8A4B0B921EA4Q33980073-6758D193-D4A6-4723-93F1-536604AE19F2Q33988335-CA932737-F1B9-4BB3-89EF-6237FB0C2958Q34035391-DBF66A1C-9FA0-49C0-9E55-AAAEEB6DAD3AQ34123724-9230EF80-A5B9-4EF7-92EF-6F31514CB819Q34425352-861F405D-6700-4F8D-A84B-FF55294ADD7FQ34458018-8FA8B1DD-9412-45F0-B416-279B0FE09654Q34463393-782EE476-1C7A-4593-99CB-4EC5C7737E4CQ34946913-52088399-9ABB-4303-8DDA-D712C253445BQ35104726-C6CB167A-A2E2-4EBF-B2D1-6019D48F147BQ35217023-A9512CF8-096E-4AFB-A0D3-A01B6A09CAE9Q35230925-A76407B1-3113-4440-9993-430A2C082E78Q35234333-BCDB90BE-45EF-4F17-997B-29C832238E95Q35560562-E0A3729A-55D3-4C04-8461-DC16B94A701AQ35636298-23FA518C-5E9B-4A28-8984-9143A7F6AE2DQ35744562-981D1A1B-BC5C-4F48-A744-69930ACA8AF3Q35868242-CD8B0ABF-2F09-4BCA-8879-D860D8968574Q35869025-1BB14341-20FD-4A9B-8736-5B05EEE5C04FQ36144663-82D3DBD9-4440-491E-AA00-13E23606F81FQ36168031-4DA77C96-8948-4096-BEF1-013173D23163Q36207714-F1670840-32F5-4D85-A123-19505B2313ABQ36247902-32679ED2-91C4-44C6-A386-130506A58F27Q36801971-812E2461-1C24-4A82-AF6A-9D1B4B71334DQ36813603-48A47A5E-B459-4976-BD45-25D3C42B6694Q36917756-13461841-429B-4421-AA77-55E466A33801Q36964131-39088E4B-EB09-4125-8798-64D95CD5ECF3Q37001327-8D86FAB6-C99B-48F6-A916-D8E01C729CBBQ37179204-5C067BF2-1793-43B7-956E-378DC020C3FEQ37259583-72389742-1EF4-4E4A-BDE0-15F426B99026Q37316047-DD172651-620F-44F3-BA3C-D66F9B6B3F8F
P2860
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@ast
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@en
type
label
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@ast
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@en
prefLabel
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@ast
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@en
P356
P1476
Anaplastic thyroid carcinoma: ...... ors, and treatment approaches.
@en
P2093
Ashok R Shaha
Chandrakanth Are
P2888
P304
P356
10.1245/ASO.2006.05.042
P577
2006-02-15T00:00:00Z
P6179
1008113051